Syntaxin Limited
Patents = 36
Forward Citations = 384
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
49 inventors (with patents filed for the assignee):
Syntaxin Limited is a leading biotechnology company specializing in the research and development of innovative medical solutions. With a focus on neurology and genetic disorders, Syntaxin aims to transform the lives of patients through groundbreaking therapeutic approaches. Through extensive scientific expertise and cutting-edge technology, Syntaxin continues to push the boundaries of medical innovation.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com